OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Paxlovid
Niraj Niraj, Sonia Mahajan, Ajay Prakash, et al.
Indian Journal of Pharmacology (2022) Vol. 54, Iss. 6, pp. 452-458
Open Access | Times Cited: 14
Niraj Niraj, Sonia Mahajan, Ajay Prakash, et al.
Indian Journal of Pharmacology (2022) Vol. 54, Iss. 6, pp. 452-458
Open Access | Times Cited: 14
Showing 14 citing articles:
Impact of extended-course oral nirmatrelvir/ritonavir in established Long COVID: a case series
Alison K. Cohen, Toni Wall Jaudon, Eric M. Schurman, et al.
Communications Medicine (2025) Vol. 4, Iss. 1
Open Access | Times Cited: 1
Alison K. Cohen, Toni Wall Jaudon, Eric M. Schurman, et al.
Communications Medicine (2025) Vol. 4, Iss. 1
Open Access | Times Cited: 1
Resistance to nirmatrelvir due to mutations in the Mpro in the subvariants of SARS-CoV-2 Omicron: Another concern?
Srijan Chatterjee, Manojit Bhattacharya, Kuldeep Dhama, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 32, pp. 263-266
Open Access | Times Cited: 25
Srijan Chatterjee, Manojit Bhattacharya, Kuldeep Dhama, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 32, pp. 263-266
Open Access | Times Cited: 25
Cardiac damage and tropism of severe acute respiratory syndrome coronavirus 2
Melina Tangos, Muhammad Jarkas, İbrahim Akın, et al.
Current Opinion in Microbiology (2024) Vol. 78, pp. 102437-102437
Open Access | Times Cited: 3
Melina Tangos, Muhammad Jarkas, İbrahim Akın, et al.
Current Opinion in Microbiology (2024) Vol. 78, pp. 102437-102437
Open Access | Times Cited: 3
Exploring the structural and molecular interaction landscape of nirmatrelvir and Mpro complex: The study might assist in designing more potent antivirals targeting SARS-CoV-2 and other viruses
Chiranjib Chakraborty, Manojit Bhattacharya, Abdulrahman Alshammari, et al.
Journal of Infection and Public Health (2023) Vol. 16, Iss. 12, pp. 1961-1970
Open Access | Times Cited: 10
Chiranjib Chakraborty, Manojit Bhattacharya, Abdulrahman Alshammari, et al.
Journal of Infection and Public Health (2023) Vol. 16, Iss. 12, pp. 1961-1970
Open Access | Times Cited: 10
Impact of extended-course oral nirmatrelvir/ritonavir (Paxlovid) in established Long COVID: Case series and research considerations
Alison K. Cohen, Toni Wall Jaudon, Eric M. Schurman, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 8
Alison K. Cohen, Toni Wall Jaudon, Eric M. Schurman, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 8
Covalent small-molecule inhibitors of SARS-CoV-2 Mpro: Insights into their design, classification, biological activity, and binding interactions
Ahmed M. Shawky, Faisal A. Almalki, Hayat Ali Alzahrani, et al.
European Journal of Medicinal Chemistry (2024) Vol. 277, pp. 116704-116704
Closed Access | Times Cited: 2
Ahmed M. Shawky, Faisal A. Almalki, Hayat Ali Alzahrani, et al.
European Journal of Medicinal Chemistry (2024) Vol. 277, pp. 116704-116704
Closed Access | Times Cited: 2
Vitamin D: A key player in COVID-19 immunity and lessons from the pandemic to combat immune-evasive variants
Hussein Sabit, Shaimaa Abdel-Ghany, Mahmoud S. Abdallah, et al.
Inflammopharmacology (2024) Vol. 32, Iss. 6, pp. 3631-3652
Open Access | Times Cited: 1
Hussein Sabit, Shaimaa Abdel-Ghany, Mahmoud S. Abdallah, et al.
Inflammopharmacology (2024) Vol. 32, Iss. 6, pp. 3631-3652
Open Access | Times Cited: 1
In Vitro Analysis of SARS-CoV-2 Spike Protein and Ivermectin Interaction
Alejandra García-Aguilar, Rebeca Campi-Caballero, Giovani Visoso-Carvajal, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16392-16392
Open Access | Times Cited: 2
Alejandra García-Aguilar, Rebeca Campi-Caballero, Giovani Visoso-Carvajal, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16392-16392
Open Access | Times Cited: 2
Current diagnostic and therapeutic approaches for severe acute respiratory syndrome coronavirus-2 (SARS-COV-2) and the role of nanomaterial-based theragnosis in combating the pandemic
Beibei Zhang, Qiulan Wu, Liping Yin, et al.
Nanotechnology Reviews (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 2
Beibei Zhang, Qiulan Wu, Liping Yin, et al.
Nanotechnology Reviews (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 2
Hierarchical Virtual Screening of SARS-CoV-2 Main Protease Potential Inhibitors: Similarity Search, Pharmacophore Modeling, and Molecular Docking Study
Huda Mando, Iyad Allous
Anti-Infective Agents (2024) Vol. 22, Iss. 4
Closed Access
Huda Mando, Iyad Allous
Anti-Infective Agents (2024) Vol. 22, Iss. 4
Closed Access
Computational Docking as a Tool in Guiding the Drug Design of Rutaecarpine Derivatives as Potential SARS-CoV-2 Inhibitors
Shengying Lin, Xiaoyang Wang, Roy Wai-Lun Tang, et al.
Molecules (2024) Vol. 29, Iss. 11, pp. 2636-2636
Open Access
Shengying Lin, Xiaoyang Wang, Roy Wai-Lun Tang, et al.
Molecules (2024) Vol. 29, Iss. 11, pp. 2636-2636
Open Access
The antipsychotic drug lurasidone inhibits coronaviruses by affecting multiple targets
Sara Baroni, Tea Carletti, Manuela Donalisio, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access
Sara Baroni, Tea Carletti, Manuela Donalisio, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access
A novel SARS-CoV-2-derived infectious vector system
Ghada Elfayres, Yong Xiao, Qinghua Pan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Ghada Elfayres, Yong Xiao, Qinghua Pan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Exploring the Molecular Mechanism of Niuxi-Mugua Formula in Treating Coronavirus Disease 2019 via Network Pharmacology, Computational Biology, and Surface Plasmon Resonance Verification
Wei Wang, Xu Cao, Y. N. Cao, et al.
Current Computer - Aided Drug Design (2023) Vol. 20, Iss. 7, pp. 1113-1129
Closed Access
Wei Wang, Xu Cao, Y. N. Cao, et al.
Current Computer - Aided Drug Design (2023) Vol. 20, Iss. 7, pp. 1113-1129
Closed Access
